Skip to main content
Tech.euFundingExplorerBeta

Rivia

Swiss bio-analytics startup

Rivia has raised €16M across 2 funding rounds from 6 investors, most recently a Series A round in Mar 2026. Based in Zurich, Switzerland; active in Software. Data as of 4 Nov 2026.

Total raised
€16M
€16,043,478
Funding rounds
2
Investors
6
distinct backers
Active since
2024-06
latest 2026-03

Funding by year

EUR raised per year · 2026 YTD
Rivia — funding by year — interactive chart.
Data table
Rivia — funding by year
2024€3.0M
2026€13M

Signals

High confidence
Raise-next likelihood43
base rate 44% for Series A
  • ▼ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood17
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector, similar size

Global coverage: FundingData